Target intelligence / Profile preview

Zika virus precursor membrane protein (prM)

Target
prM
Molecular classification
Viral structural protein, Membrane glycoprotein
01

Overview

The Zika virus precursor membrane protein (prM) is a structural component essential for the assembly and maturation of the Zika virus, a flavivirus responsible for outbreaks linked to microcephaly and neurological disorders. In immature virions, prM forms heterodimers with the envelope (E) protein, creating trimeric spikes that project from the viral lipid membrane; the pr domain at the spike's apex covers the E protein's fusion loop, preventing premature fusion in low-pH environments like the Golgi apparatus. During maturation, host furin cleaves prM into the mature membrane (M) protein and a pr peptide, enabling the virus to adopt a smooth, infectious conformation capable of entering host cells via receptor-mediated endocytosis. Incomplete cleavage results in mosaic particles with mixed immature and mature features, potentially enhancing infectivity and evading host immunity. The derived M protein integrates into the mature virion membrane, where it may form oligomeric viroporin channels that facilitate early infection stages, such as entry or uncoating, particularly at acidic pH. As a therapeutic target, prM/M influences virus egress, stability, and host interaction, with inhibitors like rimantadine blocking M channel activity to reduce viremia in preclinical models.

Other names
pre-membrane proteinprecursor M proteinpre-envelope protein
02

Mechanism of action

Channel blockade of M protein viroporin activity during virus entry

03

Biological functions

Virus particle assemblyVirus maturationProtection of envelope fusion loopVirus-host cell interaction
04

Disease associations

Infection (Zika virus disease)
05

Interacting drugs

Rimantadine

Beyond the preview

Go deeper on Zika virus precursor membrane protein (prM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zika virus precursor membrane protein (prM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call